Description

Cytidine, 2-Deoxy-5-(Iodo-125I)- CAS NO 64792-95-6 is a radiolabeled nucleoside analog, specifically a derivative of deoxycytidine where iodine-125 is incorporated at the 5-position. This compound is critical for research and development in molecular biology and radiopharmaceuticals, enabling precise tracking and quantification in biological systems. It is primarily utilized by pharmaceutical R&D teams, diagnostic developers, and academic researchers working on nucleic acid metabolism, radiotracer development, and targeted cancer therapies.

Application

• Radiopharmaceutical Precursor: Serves as a key intermediate in the synthesis of radiolabeled probes and therapeutic agents for oncology and diagnostic imaging.
• Molecular Biology Research: Used as a tracer in studies of DNA/RNA synthesis, repair mechanisms, and nucleoside metabolism.
• Antiviral & Anticancer Agent Development: Employed in the research and screening of novel compounds that target viral replication or cancer cell proliferation.
• Biochemical Assays: Functions as a labeled substrate in enzymatic assays to study kinase or transferase activity.
• Diagnostic Kit Manufacturing: Incorporated into in-vitro diagnostic (IVD) kits for research use in detecting specific biological pathways.
• Metabolic Pathway Tracing: Enables autoradiography and other techniques to visualize and quantify the incorporation of nucleosides into cellular macromolecules.

Basic Information

Product Name	Cytidine, 2-Deoxy-5-(Iodo-125I)-
CAS No.	64792-95-6
Molecular Formula	C9H12IN3O4 *
Molecular Weight	Contact for details
Synonyms	5-Iodo-2'-deoxycytidine-125I; 5-[125I]Iodo-2'-deoxycytidine; 2'-Deoxy-5-iodocytidine-125I; 5-Iododeoxycytidine-125I; dCyd(125I); 1-(2-Deoxy-β-D-ribofuranosyl)-5-iodo-125I-cytosine; 5-Iodo-1-(2-deoxy-β-D-ribofuranosyl)cytosine-125I; NSC 39661-125I
EINECS	Contact for details

* Formula shown for non-radioactive analog; exact formula for radioactive product depends on specific activity and formulation.

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards. Each batch is controlled for radiochemical purity, specific activity, and chemical identity. Certificates of Analysis (COA) detailing radionuclidic purity, HPLC analysis, and sterility (where applicable) are available upon request. Production follows cGMP guidelines for critical pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store at the temperature specified on the label, typically between 2-8°C or as recommended for the specific radioactive formulation. Store in accordance with all local, national, and international regulations for radioactive materials. Keep away from food, drink, and feedstuffs.

Specification

Item	Specification
Appearance	Solution (colorless to pale yellow)
Identification (HPLC/TLC)	Conforms to reference standard
Radiochemical Purity (HPLC)	≥ 95%
Specific Activity	Contact for details
Radionuclidic Purity	≥ 99%
Chemical Purity (HPLC)	≥ 90%
Solvent (e.g., Ethanol)	Specified on COA
pH	Specified on COA

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.